iotrolan has been researched along with Joint Diseases in 2 studies
iotrolan: nonionic, isotonic contrast medium designed for intrathecal use; RN given refers to cpd without isomeric designation; DL-3-117 refers to stereoisomer; structure given in first source
Joint Diseases: Diseases involving the JOINTS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carmont, MR | 1 |
| Tomlinson, JE | 1 |
| Blundell, C | 1 |
| Davies, MB | 1 |
| Moore, DJ | 1 |
| Kreitner, KF | 1 |
| Loew, R | 1 |
| Runkel, M | 1 |
| Zöllner, J | 1 |
| Thelen, M | 1 |
2 other studies available for iotrolan and Joint Diseases
| Article | Year |
|---|---|
Variability of joint communications in the foot and ankle demonstrated by contrast-enhanced diagnostic injections.
Topics: Anesthetics, Local; Cohort Studies; Contrast Media; Extravasation of Diagnostic and Therapeutic Mate | 2009 |
Low-field MR arthrography of the shoulder joint: technique, indications, and clinical results.
Topics: Arthrography; Contrast Media; Cost Control; Gadolinium DTPA; Humans; Image Enhancement; Image Proces | 2003 |